BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 16537404)

  • 21. Efficacy of cocktail phage therapy in treating Vibrio cholerae infection in rabbit model.
    Jaiswal A; Koley H; Ghosh A; Palit A; Sarkar B
    Microbes Infect; 2013 Feb; 15(2):152-6. PubMed ID: 23159467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice.
    Jaiswal A; Koley H; Mitra S; Saha DR; Sarkar B
    Int J Med Microbiol; 2014 May; 304(3-4):422-30. PubMed ID: 24656386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera transmission: the host, pathogen and bacteriophage dynamic.
    Nelson EJ; Harris JB; Morris JG; Calderwood SB; Camilli A
    Nat Rev Microbiol; 2009 Oct; 7(10):693-702. PubMed ID: 19756008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence, significance & molecular epidemiology of cholera outbreaks in West Bengal.
    Sur D; Dutta S; Sarkar BL; Manna B; Bhattacharya MK; Datta KK; Saha A; Dutta B; Pazhani GP; Choudhuri AR; Bhattacharya SK
    Indian J Med Res; 2007 Jun; 125(6):772-6. PubMed ID: 17704555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phage predation, disease severity, and pathogen genetic diversity in cholera patients.
    Madi N; Cato ET; Abu Sayeed M; Creasy-Marrazzo A; Cuénod A; Islam K; Khabir MIU; Bhuiyan MTR; Begum YA; Freeman E; Vustepalli A; Brinkley L; Kamat M; Bailey LS; Basso KB; Qadri F; Khan AI; Shapiro BJ; Nelson EJ
    Science; 2024 Apr; 384(6693):eadj3166. PubMed ID: 38669570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EFFECT OF MUKERJEE'S GROUP IV PHAGE ON EL TOR VIBRIOS.
    MONSUR KA; RIZVI SS; HUQ MI; BENENSON AS
    Bull World Health Organ; 1965; 32(2):211-6. PubMed ID: 14310908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholera in the Gilbert Island. I. Epidemiological features.
    Kuberski T; Flood T; Tera T
    Am J Trop Med Hyg; 1979 Jul; 28(4):677-84. PubMed ID: 464187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolutionary consequences of intra-patient phage predation on microbial populations.
    Seed KD; Yen M; Shapiro BJ; Hilaire IJ; Charles RC; Teng JE; Ivers LC; Boncy J; Harris JB; Camilli A
    Elife; 2014 Aug; 3():e03497. PubMed ID: 25161196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cholera outbreak associated with drinking contaminated well water.
    Ranjbar R; Rahbar M; Naghoni A; Farshad S; Davari A; Shahcheraghi F
    Arch Iran Med; 2011 Sep; 14(5):339-40. PubMed ID: 21888459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of phages in the epidemiology of cholera.
    Faruque SM
    Curr Top Microbiol Immunol; 2014; 379():165-80. PubMed ID: 24213557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage types of Vibrio cholerae O1 and O139 in the past decade in India.
    Sarkar BL; Bhowmick TS; Das M; Rajendran K; Nair GB
    Jpn J Infect Dis; 2011; 64(4):312-5. PubMed ID: 21788707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Monoclonal Antibody to a Vibriophage as a Proxy for Vibrio cholerae Detection.
    Sayeed MA; Paisie T; Alam MT; Ali A; Camilli A; Wrammert J; Khan AI; Qadri F; Salemi M; Morris JG; Nelson EJ
    Infect Immun; 2022 Aug; 90(8):e0016122. PubMed ID: 35862704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consecutive outbreaks of Vibrio cholerae O139 and V. cholerae O1 cholera in a fishing village near Karachi, Pakistan.
    Siddiqui FJ; Bhutto NS; von Seidlein L; Khurram I; Rasool S; Ali M; Zafar A; Deen JL; Clemens JD; Nizami Q; Bhutta ZA
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):476-82. PubMed ID: 16443247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reviving Phage Therapy for the Treatment of Cholera.
    Bhandare S; Colom J; Baig A; Ritchie JM; Bukhari H; Shah MA; Sarkar BL; Su J; Wren B; Barrow P; Atterbury RJ
    J Infect Dis; 2019 Feb; 219(5):786-794. PubMed ID: 30395214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mathematical model for Vibrio-phage interactions.
    Botelho C; Dzevela Kong J; Ali Ber Lucien M; Shuai Z; Wang H
    Math Biosci Eng; 2021 Mar; 18(3):2688-2712. PubMed ID: 33892567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular comparison of toxigenic clinical & non-toxigenic environmental strains of Vibrio cholerae O1 Ogawa isolated during an outbreak of cholera in south India.
    Sinha S; Chowdhury P; Chowdhury NR; Kamruzzaman M; Faruque SM; Ramamurthy T; Bhattacharya SK; Yamasaki S; Takeda Y; Nair GB
    Indian J Med Res; 2001 Sep; 114():83-9. PubMed ID: 11873402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and proliferation of the lysogenic bacteriophage CTXΦ in Vibrio cholerae.
    Fan F; Kan B
    Virol Sin; 2015 Feb; 30(1):19-25. PubMed ID: 25613689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A highly specific phage defense system is a conserved feature of the Vibrio cholerae mobilome.
    O'Hara BJ; Barth ZK; McKitterick AC; Seed KD
    PLoS Genet; 2017 Jun; 13(6):e1006838. PubMed ID: 28594826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological, microbiological & electron microscopic study of a cholera outbreak in a Kolkata slum community.
    Sur D; Sarkar BL; Manna B; Deen J; Datta S; Niyogi SK; Ghosh AN; Deb A; Kanungo S; Palit A; Bhattacharya SK
    Indian J Med Res; 2006 Jan; 123(1):31-6. PubMed ID: 16567865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria.
    Karaolis DK; Somara S; Maneval DR; Johnson JA; Kaper JB
    Nature; 1999 May; 399(6734):375-9. PubMed ID: 10360577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.